{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T09:43:06Z","timestamp":1792057386288,"version":"4.4.0"},"reference-count":6,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Psychiatry"],"published-print":{"date-parts":[[2023,1,1]]},"abstract":"<jats:p>This cohort study examines racial and ethnic differences in the duration of buprenorphine treatment for opioid use disorder in the US from 2006 to 2020.<\/jats:p>","DOI":"10.1001\/jamapsychiatry.2022.3673","type":"journal-article","created":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T16:00:41Z","timestamp":1668009641000},"page":"93","source":"Crossref","is-referenced-by-count":44,"title":["Racial and Ethnic Disparities in Buprenorphine Treatment Duration in the US"],"prefix":"10.1001","volume":"80","author":[{"given":"Huiru","family":"Dong","sequence":"first","affiliation":[{"name":"Massachusetts General Hospital Institute for Technology Assessment, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin J.","family":"Stringfellow","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital Institute for Technology Assessment, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Alton","family":"Russell","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad S.","family":"Jalali","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital Institute for Technology Assessment, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"5","key":"yld220008r1","doi-asserted-by":"publisher","first-page":"753","DOI":"10.7326\/M22-0150","article-title":"Shifting focus to evidence-based management of substance use disorders.","volume":"175","author":"Wakeman","year":"2022","journal-title":"Ann Intern Med"},{"issue":"2","key":"yld220008r3","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1176\/appi.ajp.2019.19060612","article-title":"Acute care, prescription opioid use, and overdose following discontinuation of long-term buprenorphine treatment for opioid use disorder.","volume":"177","author":"Williams","year":"2020","journal-title":"Am J Psychiatry"},{"key":"yld220008r4","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jsat.2016.12.010","article-title":"Long-term retention in office based opioid treatment with buprenorphine.","volume":"74","author":"Weinstein","year":"2017","journal-title":"J Subst Abuse Treat"},{"issue":"8","key":"yld220008r5","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/S2215-0366(22)00160-2","article-title":"Racial and ethnic differences in alcohol, cannabis, and illicit substance use treatment: a systematic review and narrative synthesis of studies done in the USA.","volume":"9","author":"Jordan","year":"2022","journal-title":"Lancet Psychiatry"},{"issue":"29","key":"yld220008r6","doi-asserted-by":"publisher","first-page":"940","DOI":"10.15585\/mmwr.mm7129e2","article-title":"Vital signs: drug overdose deaths, by selected sociodemographic and social determinants of health characteristics\u201425 states and the District of Columbia, 2019-2020.","volume":"71","author":"Kariisa","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"yld220008r2","unstructured":"National Quality Forum. Behavioral health 2016-2017: final report. August 2017. Accessed March 14, 2022. https:\/\/www.qualityforum.org\/Publications\/2017\/08\/Behavioral_Health_2016-2017_Final_Report.aspx"}],"container-title":["JAMA Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/articlepdf\/2798512\/jamapsychiatry_dong_2022_ld_220008_1671567535.67093.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T16:02:45Z","timestamp":1672848165000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/fullarticle\/2798512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,1]]},"references-count":6,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapsychiatry.2022.3673","relation":{},"ISSN":["2168-622X"],"issn-type":[{"value":"2168-622X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1,1]]}}}